Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Upstream Bio (UPB) Research & Development (2023 - 2025)

Historic Research & Development for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $33.0 million.

  • Upstream Bio's Research & Development rose 11366.55% to $33.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $118.4 million, marking a year-over-year increase of 12448.67%. This contributed to the annual value of $63.0 million for FY2024, which is 9801.25% up from last year.
  • Latest data reveals that Upstream Bio reported Research & Development of $33.0 million as of Q3 2025, which was up 11366.55% from $37.9 million recorded in Q2 2025.
  • Over the past 5 years, Upstream Bio's Research & Development peaked at $37.9 million during Q2 2025, and registered a low of $7.8 million during Q3 2023.
  • Over the past 3 years, Upstream Bio's median Research & Development value was $15.4 million (recorded in 2024), while the average stood at $19.9 million.
  • Per our database at Business Quant, Upstream Bio's Research & Development surged by 8844.56% in 2024 and then soared by 16913.78% in 2025.
  • Quarter analysis of 3 years shows Upstream Bio's Research & Development stood at $11.6 million in 2023, then skyrocketed by 88.45% to $21.8 million in 2024, then soared by 51.45% to $33.0 million in 2025.
  • Its Research & Development stands at $33.0 million for Q3 2025, versus $37.9 million for Q2 2025 and $25.8 million for Q1 2025.